Global, regional, and national burden and quality of care index (QCI) of bipolar disorder: A systematic analysis of the Global Burden of Disease Study 1990 to 2019

被引:5
|
作者
Aghababaie-Babaki, Paria [1 ]
Malekpour, Mohammad-Reza [1 ]
Mohammadi, Esmaeil [1 ,2 ]
Moghaddam, Sahar Saeedi [1 ,3 ]
Rashidi, Mohammad-Mahdi [1 ]
Ghanbari, Ali [1 ]
Heidari-Foroozan, Mahsa [4 ]
Esfahani, Zahra [1 ,5 ]
Fateh, Sahar Mohammadi [1 ]
Hajebi, Amirali [1 ]
Haghshenas, Rosa [1 ]
Mehr, Elmira Foroutan [1 ]
Rezaei, Negar [1 ,6 ,7 ]
Larijani, Bagher [6 ]
Farzadfar, Farshad [1 ,6 ]
机构
[1] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Tehran, Iran
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol Surg, Oklahoma City, OK USA
[3] Kiel Inst World Econ, Kiel, Germany
[4] Shahid Beheshti Univ Med Sci, Student Res Ctr Comm, Sch Med, Tehran, Iran
[5] Univ Social Welf & Rehabil Sci, Dept Biostat, Tehran, Iran
[6] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran
[7] Univ Tehran Med Sci, Endocrinol & Metab Populat Sci Inst, Noncommunicable Dis Res Ctr, Second Floor 10, Tehran 1411713137, Iran
关键词
Quality of care index; global burden of disease; bipolar disorders; quality of health care; mental health; MENTAL-DISORDERS; HEALTH; METAANALYSIS; EPISODES; CANCER; TRENDS; INCOME;
D O I
10.1177/00207640231182358
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Bipolar disorders (BD) are significant debilitating mental problems. Here, we introduced a novel index as a representative of the quality of care delivered to BD patients worldwide. Methods: The Global Burden of Disease (GBD) 2019 study was the primary data source on BD, including prevalence, incidence, and years lived with disability (YLDs). Secondary indices were created and transformed into a single component that accounted for most of the variation, using the Principal Component Analysis (PCA) method. This component, reported on a scale of 0 to 100, was presented as the quality of care index (QCI). The QCI was estimated in different age groups and areas within a 30-year time frame. Gender disparity ratio (GDR), as the female-to-male ratio of the QCI, was reported. Results: The Global QCI slightly increased from 50.4 in 1990 to 53.1 in 2019. The GDR value was 0.95 in 2019. The high-middle SDI quintile had the highest QCI estimate of 63.0, and the lowest QCI value of 36.9 was regarding the low SDI quintile. Western-Pacific Region and South-East Asia had the highest and lowest QCI among WHO regions, with estimates of 70.7 and 31.2, respectively. The age group of 20 to 24 years old patients reported the lowest QCI estimate of 30.2, and the highest QCI of 59.8 was regarding 40 to 44 years old patients. Conclusion: The QCI in BD had only a subtle increase from 1990 to 2019 and is in need of further improvement. Inequalities between different regions and age groups are considerable and require proper attention.
引用
收藏
页码:1958 / 1970
页数:13
相关论文
共 50 条
  • [1] The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019
    Nejadghaderi, Seyed Aria
    Roshani, Shahin
    Mohammadi, Esmaeil
    Yoosefi, Moein
    Rezaei, Negar
    Esfahani, Zahra
    Azadnajafabad, Sina
    Ahmadi, Naser
    Shahin, Sarvenaz
    Kazemi, Ameneh
    Shabestari, Alireza Namazi
    Khosravi, Ardeshir
    Mokdad, Ali H.
    Larijani, Bagher
    Farzadfar, Farshad
    PLOS ONE, 2022, 17 (04):
  • [2] 'A Global, Regional, and National Survey on Burden and Quality of Care Index (QCI) of Multiple Sclerosis; Global Burden of Disease Systematic Analysis 1990-2019'
    Maroufi, Seyed Farzad
    Shobeiri, Parnian
    Mohammadi, Esmaeil
    Azadnajafabad, Sina
    Malekpour, Mohammad-Reza
    Ghasemi, Erfan
    Rashidi, Mohammad-Mahdi
    Saeedi Moghaddam, Sahar
    Rezaei, Nazila
    Sharifnejad Tehrani, Yeganeh
    Mohammadi Fateh, Sahar
    Ahmadi, Naser
    Farzi, Yosef
    Rezaei, Negar
    Larijani, Bagher
    NEUROEPIDEMIOLOGY, 2023, 57 (06) : 400 - 412
  • [3] Global, regional, and national survey on burden and Quality of Care Index (QCI) of orofacial clefts: Global burden of disease systematic analysis 1990-2019
    Sofi-Mahmudi, Ahmad
    Shamsoddin, Erfan
    Khademioore, Sahar
    Khazaei, Yeganeh
    Vahdati, Amin
    Tovani-Palone, Marcos Roberto
    PLOS ONE, 2025, 20 (01):
  • [4] Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990-2017
    Azadnajafabad, Sina
    Moghaddam, Sahar Saeedi
    Mohammadi, Esmaeil
    Rezaei, Negar
    Ghasemi, Erfan
    Fattahi, Nima
    Aminorroaya, Arya
    Azadnajafabad, Reza
    Aryannejad, Armin
    Rezaei, Nazila
    Naderimagham, Shohreh
    Haghpanah, Vahid
    Mokdad, Ali H.
    Gharib, Hossein
    Farzadfar, Farshad
    Larijani, Bagher
    CANCER MEDICINE, 2021, 10 (07): : 2496 - 2508
  • [5] Global, regional, and national burden and quality of care index (QCI) of oral disorders: a systematic analysis of the global burden of disease study 1990-2017
    Shoaee, Shervan
    Ghasemi, Erfan
    Sofi-Mahmudi, Ahmad
    Shamsoddin, Erfan
    Tovani-Palone, Marcos Roberto
    Roshani, Shahin
    Heydari, Mohammad-Hossein
    Yoosefi, Moein
    Masinaei, Masoud
    Azadnaejafabadi, Sina
    Mohammadi, Esmaeil
    Rezaei, Negar
    Larijani, Bagher
    Fakhrzadeh, Hossein
    Farzadfar, Farshad
    BMC ORAL HEALTH, 2024, 24 (01):
  • [6] A global, regional, and national survey on burden and Quality of Care Index (QCI) of bladder cancer: The global burden of disease study 1990-2019
    Karimi, Amirali
    Shobeiri, Parnian
    Azadnajafabad, Sina
    Masinaei, Masoud
    Rezaei, Negar
    Ghanbari, Ali
    Rezaei, Nazila
    Rouhifard, Mahtab
    Shahin, Sarvenaz
    Rashidi, Mohammad-Mahdi
    Keykhaei, Mohammad
    Kazemi, Ameneh
    Amini, Erfan
    Larijani, Bagher
    Farzadfar, Farshad
    PLOS ONE, 2022, 17 (10):
  • [7] A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017
    Mohammad Keykhaei
    Masood Masinaei
    Esmaeil Mohammadi
    Sina Azadnajafabad
    Negar Rezaei
    Sahar Saeedi Moghaddam
    Nazila Rezaei
    Maryam Nasserinejad
    Mohsen Abbasi-Kangevari
    Mohammad-Reza Malekpour
    Seyyed-Hadi Ghamari
    Rosa Haghshenas
    Kamyar Koliji
    Farzad Kompani
    Farshad Farzadfar
    Experimental Hematology & Oncology, 10
  • [8] A Global, Regional, and National Burden and Quality of Care Index for Schizophrenia: Global Burden of Disease Systematic Analysis 1990-2019
    Same, Kaveh
    Shobeiri, Parnian
    Rashidi, Mohammad-Mahdi
    Ghasemi, Erfan
    Moghaddam, Sahar Saeedi
    Mohammadi, Esmaeil
    Masinaei, Masoud
    Salehi, Niloufar
    Fateh, Sahar Mohammadi
    Maroufi, Seyed Farzad
    Abdolhamidi, Elham
    Moghimi, Mana
    Abbasi-Kangevari, Zeinab
    Rezaei, Negar
    Larijani, Bagher
    SCHIZOPHRENIA BULLETIN, 2023, 50 (05) : 1083 - 1093
  • [9] Global, regional, and national burden and quality of care index (QCI) of lip and oral cavity cancer: a systematic analysis of the Global Burden of Disease Study 1990–2017
    Ahmad Sofi-Mahmudi
    Masoud Masinaei
    Erfan Shamsoddin
    Marcos Roberto Tovani-Palone
    Mohammad-Hossein Heydari
    Shervan Shoaee
    Erfan Ghasemi
    Sina Azadnajafabad
    Shahin Roshani
    Negar Rezaei
    Mohammad-Mahdi Rashidi
    Reyhaneh Kalantar Mehrjardi
    Amir Ali Hajebi
    Bagher Larijani
    Farshad Farzadfar
    BMC Oral Health, 21
  • [10] A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990-2017
    Keykhaei, Mohammad
    Masinaei, Masood
    Mohammadi, Esmaeil
    Azadnajafabad, Sina
    Rezaei, Negar
    Saeedi Moghaddam, Sahar
    Rezaei, Nazila
    Nasserinejad, Maryam
    Abbasi-Kangevari, Mohsen
    Malekpour, Mohammad-Reza
    Ghamari, Seyyed-Hadi
    Haghshenas, Rosa
    Koliji, Kamyar
    Kompani, Farzad
    Farzadfar, Farshad
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)